More tools:Markets·Screener·Research·Chat

ClearPoint Neuro, Inc. Common Stock (CLPT) Financial Statements

ClearPoint Neuro, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001T6D542
XNAS · usd
14.05▲ 0.09 (0.64%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close13.96
Day's Range13.44 – 14.22
52-Week Range8.59 – 30.10
Volume745.3K
Avg Volume616.6K
Share Statistics
Shares Outstanding
Employees172
ExchangeXNAS
Listed2012-05-18
Share count as of July 27, 2026
Loading Income Statement…
Key questions about ClearPoint Neuro, Inc. Common Stock (CLPT)
What is ClearPoint Neuro, Inc. Common Stock's Market Cap?
ClearPoint Neuro, Inc. Common Stock's Market Cap is $428.6M, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's Enterprise Value?
ClearPoint Neuro, Inc. Common Stock's Enterprise Value is $449.5M, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's Price / Sales?
ClearPoint Neuro, Inc. Common Stock's Price / Sales is 10.1×, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's EV / Revenue?
ClearPoint Neuro, Inc. Common Stock's EV / Revenue is 10.6×, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's EV / EBITDA?
ClearPoint Neuro, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's Revenue (TTM)?
ClearPoint Neuro, Inc. Common Stock's Revenue (TTM) is $42.3M, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's Net Income (TTM)?
ClearPoint Neuro, Inc. Common Stock's Net Income (TTM) is -$34.6M, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's EBITDA?
ClearPoint Neuro, Inc. Common Stock's EBITDA is -$30.5M, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's Diluted EPS (TTM)?
ClearPoint Neuro, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.
What is ClearPoint Neuro, Inc. Common Stock's EBITDA Margin?
ClearPoint Neuro, Inc. Common Stock's EBITDA Margin is -72.1%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+18.1%+42.9%+34.0%+9.1%
Cost of revenue
Gross profit
% of revenue61.7%64.0%61.5%63.2%
Research and development costs
Sales and marketing expenses
General and administrative expenses
Operating loss
% of revenue-94.2%-69.9%-67.7%-59.5%
Other income (expense):
Other expense, net
Interest income——
Interest expense——
Interest (expense) income, net———
Net loss before income taxes
Net loss
% of revenue-104.2%-78.8%-74.8%-66.5%
Net loss per share attributable to common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)